# PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

> **NCT02325349** · PHASE2 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1 (actual)

## Conditions studied

- Advanced Head and Neck Carcinoma
- Advanced Non-small Cell Lung Carcinoma

## Interventions

- **DRUG:** radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)

## Key facts

- **NCT ID:** NCT02325349
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03-20
- **Primary completion:** 2018-09-20
- **Final completion:** 2018-09-20
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Change in protocol strategy
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325349, "PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02325349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*